• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Embolic Protection Devices Market Size

    ID: MRFR/MED/4520-HCR
    100 Pages
    Kinjoll Dey
    October 2025

    Embolic Protection Devices Market Research Report Information By Type (Distal Filter Device, Distal Occlusion Device, and Proximal Occlusion Device), By Material (Nitinol and Polyurethane), By Usage (Disposable Device and Re-Usable Device), By Application (Cardiovascular Diseases, {Coronary Artery Diseases, Trans Cather Aortic Valve Replacement, and Saphenous Vein Graft Diseases}, Neurovascular...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Embolic Protection Devices Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Embolic Protection Devices Size

    Embolic Protection Devices Market Growth Projections and Opportunities

    Embolic Protection Devices Market size is projected to reach USD 0.62 billion by 2032 at 8.4% CAGR during the forecast period. The Embolic Protection Devices (EPD) market is significantly influenced by a myriad of market factors that collectively shape its dynamics and growth trajectory. One of the primary drivers is the rising prevalence of cardiovascular diseases, including strokes and coronary artery diseases. With aging populations and the deriving from sedentary lifestyle habits that are responsible for the predicted increase of such diseases, the need for embolic protection devices that are proven to be effective has significantly raised. Front runner of the market is played by the progressions in the field of medical technology. Due to ongoing research and development work the new updated and more accurately positioned embolic protection devices has been introduced. The later improvements in technology not only improve well the performance of these devices but as well widens their field of applicability beyond the scope of cardiovascular diseases and makes them versatile. Moreover, evolving recognition between healthcare in the matter of prevention by both care providers and patients has been the catalyst for uptake of embolic protection devices among the people. Discovering and any treatment for probable embolic occurrences to lead to a better medical result for patients is nowadays a key force pushing the sales. Governments' programs and healthcare implementation strategies play a significant role in embolic protection devices market development. Building a strong social media presence is crucial in today's digital era. With millions of users connected online, companies have the opportunity to engage with their customers directly, showcase their products, and build a loyal brand following. In this article, we will discuss six ways that businesses can build a successful social media presence. When supported by adequate regulatory frameworks and reimbursement policies, choice for certain treatments involving EPDs by healthcare providers will be an incentive for them to use these devices. Therefore, this affects the wholesale market, gaining the opportunity for embolic procedures utilization. In addition, the market is becoming more driven by the spreading request for minimal methods of intervention. Due to high patient requests and also demand from the healthcare providers for minimally to non-invasive diagnosis, the demand for embolic protection devices increases. They have become one of the most important residential components in the success of minimally invasive medical procedures that have gained prominence worldwide. Competition in terms of market and available other technologies are the factors that also make the devices market dynamic in nature. Such multiple players that the market outside the competition and innovation in order to make as a result further enhancements related to the device design, functionality, and cost effectiveness. The market dynamics are further influenced by the availability and adoption of alternative technologies or approaches for addressing cardiovascular issues, posing both challenges and opportunities for the embolic protection devices market.

    Embolic Protection Devices Market Size Graph

    Market Summary

    The Global Embolic Protection Devices Market is projected to grow from 0.36 USD Billion in 2024 to 0.87 USD Billion by 2035.

    Key Market Trends & Highlights

    Embolic Protection Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 8.32 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 0.87 USD Billion, indicating robust growth.
    • in 2024, the market is valued at 0.36 USD Billion, laying a solid foundation for future expansion.
    • Growing adoption of embolic protection devices due to increasing prevalence of cardiovascular diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.36 (USD Billion)
    2035 Market Size 0.87 (USD Billion)
    CAGR (2025-2035) 8.40%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Siemens Healthcare GmbH, Hologic, Inc., Sinduri Biotec., SEKISUI MEDICAL CO., LTD., NIPRO, Danaher, Hoffman-La Roche Ltd, Thermo Fischer Scientific Inc., Abaxis, Bio-Rad Laboratories Inc., Enzo Biochem Inc.

    Market Trends

    The growing incidence of cardiac diseases and the adoption of PCI are driving market growth.

    The increasing prevalence of cardiovascular diseases is driving the demand for advanced embolic protection devices, which are essential in minimizing the risk of complications during interventional procedures.

    U.S. Food and Drug Administration (FDA)

    Embolic Protection Devices Market Market Drivers

    Market Growth Projections

    The Global Embolic Protection Devices Market Industry is projected to experience robust growth in the coming years. With a market value of 0.36 USD Billion anticipated in 2024, the industry is expected to reach 0.87 USD Billion by 2035, reflecting a compound annual growth rate of 8.32% from 2025 to 2035. This growth trajectory indicates a strong demand for embolic protection devices, driven by factors such as technological advancements, increasing cardiovascular disease prevalence, and an aging population. The market's expansion is likely to create opportunities for innovation and investment in this critical area of healthcare.

    Rising Awareness and Education

    The growing awareness among healthcare professionals and patients regarding the benefits of embolic protection devices is a significant market driver. Educational initiatives and training programs are being implemented to inform stakeholders about the advantages of these devices during cardiovascular procedures. This heightened awareness is expected to contribute to the expansion of the Global Embolic Protection Devices Market Industry. As more healthcare providers recognize the importance of embolic protection, the adoption rates of these devices are likely to increase, further supporting market growth.

    Increasing Geriatric Population

    The global demographic shift towards an aging population is a crucial driver for the embolic protection devices market. Older adults are at a higher risk for cardiovascular diseases, necessitating the use of protective devices during surgical interventions. The Global Embolic Protection Devices Market Industry is likely to see substantial growth as the geriatric population expands. This demographic trend indicates a potential increase in market value, aligning with the projected CAGR of 8.32% from 2025 to 2035. Healthcare systems are adapting to meet the needs of this population, further supporting the demand for these devices.

    Regulatory Support and Guidelines

    Supportive regulatory frameworks and clinical guidelines play a pivotal role in the growth of the Global Embolic Protection Devices Market Industry. Regulatory bodies are increasingly recognizing the importance of embolic protection during cardiovascular procedures, leading to the establishment of guidelines that promote the use of these devices. This regulatory backing not only enhances the credibility of embolic protection devices but also encourages healthcare providers to adopt them in clinical practice. As a result, the market is likely to experience accelerated growth, driven by increased utilization in line with evolving clinical standards.

    Rising Incidence of Cardiovascular Diseases

    The increasing prevalence of cardiovascular diseases globally drives the demand for embolic protection devices. As cardiovascular conditions remain a leading cause of morbidity and mortality, the need for effective interventions becomes paramount. The Global Embolic Protection Devices Market Industry is poised to benefit from this trend, with projections indicating a market value of 0.36 USD Billion in 2024. This surge in demand is likely to be fueled by advancements in medical technology and increased awareness regarding the importance of embolic protection during procedures such as transcatheter aortic valve replacement.

    Technological Advancements in Device Design

    Innovations in the design and functionality of embolic protection devices significantly enhance their efficacy and safety. The integration of advanced materials and engineering techniques has led to the development of devices that are more effective in capturing embolic debris. This trend is expected to propel the Global Embolic Protection Devices Market Industry, with a projected growth to 0.87 USD Billion by 2035. The continuous evolution of these devices, including features such as improved delivery systems and biocompatibility, suggests a promising future for their adoption in clinical settings.

    Market Segment Insights

    Embolic Protection Devices Type Insights

    The embolic protection devices market segmentation, based on type, includes distal filter devices, distal occlusion devices, and proximal occlusion devices. The distal filter device segment dominated the market, accounting for 35% of market revenue (0.12 Billion). In developing economies, category growth is driven by ease of use, lack of interference with lesion visualization, and availability in various specifications. However, the distal occlusion device is the fastest-growing category owing to rising regulatory approvals by federal government agencies and their initiatives to develop these devices.

    Embolic Protection Devices Material Insights

    The embolic protection devices market segmentation, based on material, includes nitinol and polyurethane. The nitinol category generated the most income (70.4%) owing to its unique properties and versatility in the design of embolic protection devices. However, polyurethane is the fastest-growing category due to its unique combination of properties such as mechanical strength, flexibility, biocompatibility, and low thrombogenicity.

    Embolic Protection Devices Usage Insights

    The embolic protection devices market segmentation, based on usage, includes disposable devices and re-usable devices. The disposable device category generated the most income due to the rising prevalence of chronic illnesses, such as neurological, cardiovascular, infectious, and urological disorders. However, polyurethane is the fastest-growing category due to its cost-effectiveness.

    Embolic Protection Devices Application Insights

    The embolic protection devices market segmentation, based on application, includes cardiovascular diseases, {coronary artery diseases, trans cather aortic valve replacement, saphenous vein graft diseases}, neurovascular diseases, and peripheral vascular diseases. The cardiovascular diseases category generated the most income owing to rising cases of this disease. However, peripheral vascular diseases are the fastest-growing category due to the growing vogue of minimally invasive procedures, which offer various advantages over conventional methods, such as reduced complications, quicker recovery times, and minimal invasiveness.

    Embolic Protection Devices End-User Insights

    The embolic protection devices market segmentation, based on end-user, includes hospitals & clinics, ambulatory surgical centers, and specialty centers. The hospitals & clinics category generated the most income owing to the high prevalence of highly qualified healthcare professionals and staff. However, specialty centers are the fastest-growing category due to the growing emphasis on patient safety, the adoption of technology-based solutions, and favorable reimbursement policies for endovascular procedures in specialty centers.

    Source Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Get more detailed insights about Embolic Protection Devices Market Research Report – Forecast to 2034

    Regional Insights

    By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American embolic protection devices market will dominate this market owing to increasing investments by the government, and the high rate of acceptance of newly developed items among end-users will boost the market growth in this region. Further, the German embolic protection devices market held the largest market share, and the UK embolic protection devices market was the fastest-growing market in the European region.

    Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    EMBOLIC PROTECTION DEVICES MARKET SHARE BY REGION

    Source Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Europe's embolic protection devices market accounts for the second-largest market share due to the partnerships of leading companies and technological advancements and several in this region. Further, the German embolic protection devices market held the largest market share, and the UK embolic protection devices market was the fastest-growing market in the European region.

    The Asia-Pacific embolic protection devices market is expected to grow at the fastest CAGR from 2023 to 2032. This is due to rising clinical trials in this region. Moreover, China’s embolic protection devices market held the largest market share, and the Indian embolic protection devices market was the fastest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development to expand their product lines, which will help the embolic protection devices market grow even more. Market participants are also undertaking several strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the embolic protection devices industry must offer cost-effective items.

    Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the embolic protection devices industry to benefit clients and increase the market sector. Major players in the embolic protection devices market, including Siemens Healthcare GmbH, Hologic, Inc., Sinduri Biotec., SEKISUI MEDICAL CO., LTD., NIPRO, Danaher, and others, are attempting to increase market demand by investing in research and development operations.

    Abbott Laboratories discovers, creates, manufactures and sells a diversified range of healthcare products, such as branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products. The firm also offers various medical devices, including heart failure, electrophysiology, vascular and structural heart devices, rhythm management, and neuromodulation devices. The firm also delivers minerals and nutrition products and dietary supplements. It has research and development facilities across the world. In September 2021, Abbott acquired Walk Vascular, a commercial-stage medical device company that develops minimally invasive mechanical aspiration thrombectomy systems to remove peripheral blood clots.

    Cardiovascular Systems Inc, a subsidiary of Abbott Laboratories, is a medical device firm that develops and commercializes products for treating peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy systems, coronary orbital atherectomy systems, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system used to treat OAS atherosclerotic disease in peripheral arteries. CSI offers accessories such as guide wires, lubricants, infusion pumps and ancillary products. It has developed orbital atherectomy systems technology for peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases.

    In November 2021, Cardiovascular Systems, Inc. launched a voluntary recall of the WIRION Embolic Protection System.

    Key Companies in the Embolic Protection Devices Market market include

    Industry Developments

    • Q2 2025: Terumo Interventional Systems launches FDA-approved ROADSAVERTM Carotid Stent System in the U.S. Terumo Interventional Systems announced the U.S. launch of its FDA-approved ROADSAVERTM Carotid Stent System, which is used in conjunction with the Nanoparasol® Embolic Protection System to offer enhanced flexibility and embolization prevention for carotid artery procedures.

    Future Outlook

    Embolic Protection Devices Market Future Outlook

    The Global Embolic Protection Devices Market is projected to grow at an 8.40% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of cardiovascular diseases, and rising demand for minimally invasive procedures.

    New opportunities lie in:

    • Develop next-generation bioresorbable embolic protection devices to enhance patient outcomes.
    • Expand market presence in emerging economies through strategic partnerships and localized manufacturing.
    • Leverage digital health technologies to integrate embolic protection devices with remote monitoring systems.

    By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in innovative cardiovascular solutions.

    Market Segmentation

    Embolic Protection Devices Type Outlook

    • Distal Filter Device
    • Distal Occlusion Device
    • Proximal Occlusion Device

    Embolic Protection Devices Usage Outlook

    • Disposable Device
    • Re-Usable Device

    Embolic Protection Devices End-User Outlook

    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Specialty Centers

    Embolic Protection Devices Material Outlook

    • Nitinol
    • Polyurethane

    Embolic Protection Devices Regional Outlook

    North America
    • US
    • Canada

    Embolic Protection Devices Application Outlook

    • Cardiovascular Diseases
    • Coronary Artery Diseases
    • Trans Cather Aortic Valve Replacement
    • Saphenous Vein Graft Diseases
    • Neurovascular Diseases
    • Peripheral Vascular Diseases

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024    0.36 (USD Billion)
    Market Size 2025    0.39 (USD Billion)
    Market Size 2035 0.87 (USD Billion)
    Compound Annual Growth Rate (CAGR) 8.40% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Type, Material, Usage, Application, End-User and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Siemens Healthcare GmbH, Hologic, Inc., Sinduri Biotec., SEKISUI MEDICAL CO., LTD., NIPRO, Danaher, F. Hoffman-La Roche Ltd, Abbott, Thermo Fischer Scientific Inc., Abaxis, Bio-Rad Laboratories Inc., and Enzo Biochem Inc.
    Key Market Opportunities The expansion in the demand for minimally invasive procedures.
    Key Market Dynamics Rise in the number of research and development activities

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    How much is the embolic protection devices market?

    The embolic protection devices market size was valued at USD 0.3 Billion in 2022.

    What is the growth rate of the embolic protection devices market?

    The market is projected to grow at a CAGR of 8.40% during the forecast period, 2025-2034.

    Which region held the largest market share in the embolic protection devices market?

    North America had the largest share of the market

    Who are the key players in the embolic protection devices market?

    The key players in the market are SEKISUI MEDICAL CO., LTD., NIPRO, Danaher, F. Hoffman-La Roche Ltd, Abbott, Thermo Fischer Scientific Inc., Abaxis, Bio-Rad Laboratories Inc., and Enzo Biochem Inc.

    Which type led the embolic protection devices market?

    The distal filter device category dominated the market in 2022.

    Which material had the largest market share in the embolic protection devices market?

    Nitinol had the largest share in the market.

    Which usage led the embolic protection devices market?

    The disposable device category dominated the market in 2022.

    Which application had the largest market share in the market?

    Cardiovascular diseases have the largest share in the market.

    Which end-user led the embolic protection devices market?

    The hospitals & clinics category dominated the market in 2022.

    1. Table Of Content
    2. Report Prologue
    3. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Technology Trends & Assessment
    6. Market Factor Analysis
      1. Porter’s Five Forces Analysis
        1. Bargaining Power Of Suppliers
        2. Bargaining Power Of Buyers
        3. Threat Of New Entrants
        4. Threat Of Substitutes
        5. Intensity Of Rivalry
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    7. Global Embolic Protection Devices Market, By Type
      1. Introduction
      2. Distal Filter Devices
    8. • Market Estimates & Forecast, 2023-2032
    9. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. Distal Occlusion Devices
    10. • Market Estimates & Forecast, 2023-2032
    11. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. Proximal Occlusion Devices
    12. • Market Estimates & Forecast, 2023-2032
    13. Global Embolic Protection Devices Market, By Material
      1. Introduction
      2. Nitinol
    14. • Market Estimates & Forecast, By Region/Country, 2023-2032
      1. Polyurethane
    15. • Market Estimates & Forecast, 2023-2032
    16. • Market Estimates & Forecast, By Region/Country, 2023-2032
    17. Global Embolic Protection Devices Market, By Usage
      1. Introduction
      2. Disposable Devices
    18. • Market Estimates & Forecast, 2023-2032
      1. Re-Usable Devices
    19. Global Embolic Protection Devices Market, By Application
      1. Introduction
      2. Cardiovascular Diseases
        1. Coronary Artery Diseases
        2. Trans Cather Aortic Valve Replacement
        3. Saphenous Vein Graft Disease
      3. Neurovascular Diseases
      4. Peripheral Vascular Diseases
    20. Global Embolic Protection Devices Market, By End-User
      1. Introduction
      2. Hospitals & Clinics
      3. Ambulatory Surgical Centers
      4. Specialty Centers
    21. • Market Estimates & Forecast, By Region/Country, 2023-2032
    22. Global Embolic Protection Devices Market, By Region
      1. Introduction
      2. Americas
    23. • Market Estimates & Forecast, By Region, 2023-2032
    24. • Market Estimates & Forecast, By Type, 2023-2032
    25. • Market Estimates & Forecast, By Material, 2023-2032
    26. • Market Estimates & Forecast, By Usage, 2023-2032
    27. • Market Estimates & Forecast, By Application, 2023-2032
    28. • Market Estimates & Forecast, By End-User, 2023-2032
      1. North America
    29. • Market Estimates & Forecast, By Country, 2023-2032
    30. • Market Estimates & Forecast, By Type, 2023-2032
    31. • Market Estimates & Forecast, By Material, 2023-2032
    32. • Market Estimates & Forecast, By Usage, 2023-2032
    33. • Market Estimates & Forecast, By Application, 2023-2032
      1. U.S.
    34. • Market Estimates & Forecast, By Type, 2023-2032
    35. • Market Estimates & Forecast, By Material, 2023-2032
    36. • Market Estimates & Forecast, By Usage, 2023-2032
    37. • Market Estimates & Forecast, By Application, 2023-2032
    38. • Market Estimates & Forecast, By End-User, 2023-2032
      1. Canada
    39. • Market Estimates & Forecast, By Type, 2023-2032
    40. • Market Estimates & Forecast, By Usage, 2023-2032
    41. • Market Estimates & Forecast, By Application, 2023-2032
    42. • Market Estimates & Forecast, By End-User, 2023-2032
      1. South America
      2. Europe
        1. Western Europe
    43. • Market Estimates & Forecast, By Type, 2023-2032
    44. • Market Estimates & Forecast, By Material, 2023-2032
    45. • Market Estimates & Forecast, By End-User, 2023-2032
      1. Italy
        1. Spain
        2. Eastern Europe
    46. • Market Estimates & Forecast, By Material, 2023-2032
    47. • Market Estimates & Forecast, By Usage, 2023-2032
      1. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. Republic Of Korea
    48. • Market Estimates & Forecast, By Type, 2023-2032
      1. Rest Of Asia Pacific
      2. The Middle East & Africa
    49. • Market Estimates & Forecast, By Region, 2023-2032
      1. United Arab Emirates
        1. Saudi Arabia
        2. Oman
        3. Kuwait
        4. Qatar
        5. Rest Of The Middle East & Africa
    50. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
        1. Key Developments
    51. Company Profiles
      1. Medtronic
        1. Company Overview
        2. Product Overview
        3. Financials
        4. SWOT Analysis
      2. Abbott Laboratories
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      3. Boston Scientific
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      4. Cordis
        1. Company Overview
        2. Product/Business Segment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      5. Contego Medical
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
      6. Silk Road Medical
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
      7. Edwards Lifesciences Corporation
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      8. Allium Medical Solutions Ltd.
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      9. Cardinal Health
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      10. Angioslide
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      11. Claret Medical
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      12. LEPU MEDICAL TECHNOLOGY
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      13. W. L. Gore & Associates
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
    52. MRFR Conclusion
      1. Key Findings
        1. From CEO’s View Point
        2. Unmet Needs Of The Market
      2. Key Companies To Watch
      3. Prediction Of Pharmaceutical Industry
    53. Appendix
    54. List of Tables and Figures
      1. LIST OF TABLES
      2. Table 1 Embolic Protection Devices Industry Synopsis, 2023-2032
      3. Table 2 Global Embolic Protection Devices Market Estimates And Forecast, 2023-2032, (USD Million)
      4. Table 3 Global Embolic Protection Devices Market, By Region, 2023-2032, (USD Million)
      5. Table 5 Global Embolic Protection Devices Market, By Type, 2023-2032, (USD Million)
      6. Table 5 Global Embolic Protection Devices Market, By Material, 2023-2032, (USD Million)
      7. Table 6 Global Embolic Protection Devices Market, By Application, 2023-2032, (USD Million)
      8. Table 7 Global Embolic Protection Devices Market, By End-User, 2023-2032, (USD Million)
      9. Table 8 North America Embolic Protection Devices Market, By Type, 2023-2032, (USD Million)
      10. Table 9 North America Embolic Protection Devices Market, By Application, 2023-2032, (USD Million)
      11. Table 9 North America Embolic Protection Devices Market, By Material, 2023-2032, (USD Million)
      12. Table 10 North America Embolic Protection Devices Market, By End-User, 2023-2032, (USD Million)
      13. Table 11 U.S. Embolic Protection Devices Market, By Type, 2023-2032, (USD Million)
      14. Table 12 U.S. Embolic Protection Devices Market, By Application, 2023-2032, (USD Million)
      15. Table 12 U.S. Embolic Protection Devices Market, By Material, 2023-2032, (USD Million)
      16. Table 13 U.S. Embolic Protection Devices Market, By End-User, 2023-2032, (USD Million)
      17. Table 14 Canada Embolic Protection Devices Market, By Type, 2023-2032, (USD Million)
      18. Table 14 Canada Embolic Protection Devices Market, By Material, 2023-2032, (USD Million)
      19. Table 15 Canada Embolic Protection Devices Market, By Application, 2023-2032, (USD Million)
      20. Table 16 Canada Embolic Protection Devices Market, By End-User, 2023-2032, (USD Million)
      21. Table 17 South America Embolic Protection Devices Market, By Type, 2023-2032, (USD Million)
      22. Table 18 South America Embolic Protection Devices Market, By Application, 2023-2032, (USD Million)
      23. Table 19 South America Embolic Protection Devices Market, By End-User, 2023-2032, (USD Million)
      24. Table 20 Europe Embolic Protection Devices Market, By Type, 2023-2032, (USD Million)
      25. Table 21 Europe Embolic Protection Devices Market, By Application, 2023-2032, (USD Million)
      26. Table 22 Europe Embolic Protection Devices Market, By End-User, 2023-2032, (USD Million)
      27. Table 23 Western Europe Embolic Protection Devices Market, By Type, 2023-2032, (USD Million)
      28. Table 24 Western Europe Embolic Protection Devices Market, By Application, 2023-2032, (USD Million)
      29. Table 25 Western Europe Embolic Protection Devices Market, By End-User, 2023-2032, (USD Million)
      30. Table 26 Eastern Europe Embolic Protection Devices Market, By Type, 2023-2032, (USD Million)
      31. Table 27 Eastern Europe Embolic Protection Devices Market, By Application, 2023-2032, (USD Million)
      32. Table 28 Eastern Europe Embolic Protection Devices Market, By End-User, 2023-2032, (USD Million)
      33. Table 29 Asia Pacific Embolic Protection Devices Market, By Type, 2023-2032, (USD Million)
      34. Table 30 Asia Pacific Embolic Protection Devices Market, By Application, 2023-2032, (USD Million)
      35. Table 31 Asia Pacific Embolic Protection Devices Market, By End-User, 2023-2032, (USD Million)
      36. Table 32 Middle East & Africa Embolic Protection Devices Market, By Type, 2023-2032, (USD Million)
      37. Table 33 Middle East & Africa Embolic Protection Devices Market, By Diagnoses, 2023-2032, (USD Million)
      38. Table 34 Middle East & Africa Embolic Protection Devices Market, By End-User, 2023-2032, (USD Million)   LIST OF FIGURES
      39. Figure 1 Research Process
      40. Figure 2 Segmentation For Global Embolic Protection Devices Market
      41. Figure 3 Segmentation Market Dynamics For Embolic Protection Devices Market
      42. Figure 4 Global Embolic Protection Devices Market Share, By Type 2020
      43. Figure 5 Global Embolic Protection Devices Market Share, By Material 2020
      44. Figure 6 Global Embolic Protection Devices Market Share, By End-User, 2020
      45. Figure 7 Global Embolic Protection Devices Market Share, By Region, 2020
      46. Figure 8 North America Embolic Protection Devices Market Share, By Country, 2020
      47. Figure 9 Europe Embolic Protection Devices Market Share, By Country, 2020
      48. Figure 10 Asia Pacific Embolic Protection Devices Market Share, By Country, 2020
      49. Figure 11 Middle East & Africa Embolic Protection Devices Market Share, By Country, 2020
      50. Figure 12 Global Embolic Protection Devices Market: Company Share Analysis, 2020 (%)
      51. Figure 13 Abbott Laboratories: Key Financials
      52. Figure 14 Abbott Laboratories: Segmental Revenue
      53. Figure 16 Abbott Laboratories: Geographical Revenue
      54. Figure 17 Medtronic. Key Financials
      55. Figure 18 Medtronic: Segmental Revenue
      56. Figure 19 Medtronic: Geographical Revenue
      57. Figure 20 Contego Medical: Key Financials
      58. Figure 21 Contego Medical: Segmental Revenue
      59. Figure 22 Contego Medical: Geographical Revenue
      60. Figure 23 Claret Medical Key Financials
      61. Figure 24 Claret Medical. Segmental Revenue
      62. Figure 25 Claret Medical. Geographical Revenue
      63. Figure 26 Edwards Lifesciences Corporation: Key Financials
      64. Figure 27 Edwards Lifesciences Corporation: Segmental Revenue
      65. Figure 28 Edwards Lifesciences Corporation. Geographical Revenue
      66. Figure 29 Angioslide. Key Financials
      67. Figure 30 Angioslide. Segmental Revenue
      68. Figure 31 Angioslide. Geographical Revenue
      69. Figure 32 Merit Medical Systems, Inc.: Key Financials
      70. Figure 33 Merit Medical Systems, Inc.: Segmental Revenue
      71. Figure 34 Merit Medical Systems, Inc.: Geographical Revenue

    Embolic Protection Devices Market Segmentation

    Embolic Protection Devices Type Outlook (USD Billion, 2018-2032)

    • Distal Filter Device
    • Distal Occlusion Device
    • Proximal Occlusion Device

    Embolic Protection Devices Material Outlook (USD Billion, 2018-2032)

    • Nitinol
    • Polyurethane

    Embolic Protection Devices Usage Outlook (USD Billion, 2018-2032)

    • Disposable Device
    • Re-Usable Device

    Embolic Protection Devices Application Outlook (USD Billion, 2018-2032)

    • Cardiovascular Diseases
      • Coronary Artery Diseases
      • Trans Cather Aortic Valve Replacement
      • Saphenous Vein Graft Diseases
    • Neurovascular Diseases
    • Peripheral Vascular Diseases

    Embolic Protection Devices End-User Outlook (USD Billion, 2018-2032)

    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Specialty Centers

    Embolic Protection Devices Regional Outlook (USD Billion, 2018-2032)

    • North America Outlook (USD Billion, 2018-2032)

      • North America Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • North America Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • North America Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • North America Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • North America Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • US Outlook (USD Billion, 2018-2032)

      • US Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • US Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • US Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • US Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • US Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • CANADA Outlook (USD Billion, 2018-2032)

      • CANADA Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • CANADA Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • CANADA Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • CANADA Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • CANADA Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

    • Europe Outlook (USD Billion, 2018-2032)

      • Europe Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Europe Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Europe Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Europe Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Europe Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • Germany Outlook (USD Billion, 2018-2032)

      • Germany Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Germany Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Germany Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Germany Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Germany Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • France Outlook (USD Billion, 2018-2032)

      • France Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • France Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • France Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • France Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • France Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • UK Outlook (USD Billion, 2018-2032)

      • UK Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • UK Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • UK Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • UK Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • UK Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • ITALY Outlook (USD Billion, 2018-2032)

      • ITALY Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • ITALY Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • ITALY Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • ITALY Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • ITALY Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • SPAIN Outlook (USD Billion, 2018-2032)

      • Spain Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Spain Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Spain Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Spain Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Spain Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • Rest Of Europe Outlook (USD Billion, 2018-2032)

      • Rest Of Europe Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Rest Of Europe Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Rest Of Europe Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Rest Of Europe Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • REST OF EUROPE Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

    • Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Asia-Pacific Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Asia-Pacific Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Asia-Pacific Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Asia-Pacific Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Asia-Pacific Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • China Outlook (USD Billion, 2018-2032)

      • China Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • China Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • China Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • China Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • China Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • Japan Outlook (USD Billion, 2018-2032)

      • Japan Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Japan Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Japan Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Japan Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Japan Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • India Outlook (USD Billion, 2018-2032)

      • India Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • India Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • India Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • India Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • India Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • Australia Outlook (USD Billion, 2018-2032)

      • Australia Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Australia Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Australia Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Australia Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Australia Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Rest of Asia-Pacific Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Rest of Asia-Pacific Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Rest of Asia-Pacific Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Rest of Asia-Pacific Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Rest of Asia-Pacific Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

    • Rest of the World Outlook (USD Billion, 2018-2032)

      • Rest of the World Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Rest of the World Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Rest of the World Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Rest of the World Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Rest of the World Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • Middle East Outlook (USD Billion, 2018-2032)

      • Middle East Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Middle East Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Middle East Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Middle East Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Middle East Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • Africa Outlook (USD Billion, 2018-2032)

      • Africa Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Africa Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Africa Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Africa Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Africa Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers

      • Latin America Outlook (USD Billion, 2018-2032)

      • Latin America Embolic Protection Devices by Type
        • Distal Filter Device
        • Distal Occlusion Device
        • Proximal Occlusion Device
      • Latin America Embolic Protection Devices by Material
        • Nitinol
        • Polyurethane
      • Latin America Embolic Protection Devices by Usage
        • Disposable Device
        • Re-Usable Device
      • Latin America Embolic Protection Devices by Application

        • Cardiovascular Diseases

          • Coronary Artery Diseases
          • Trans Cather Aortic Valve Replacement
          • Saphenous Vein Graft Diseases
        • Neurovascular Diseases
        • Peripheral Vascular Diseases
      • Latin America Embolic Protection Devices by End-User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Specialty Centers
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027